Dodd Natalie, Carey Mariko Leanne, Mansfield Elise, Oldmeadow Christopher
University of Newcastle, School of Medicine and Public Health, Faculty of Health and Medicine, Callaghan, Australia.
Hunter Medical Research Institute, New Lambton Heights, Australia.
JMIR Res Protoc. 2017 May 10;6(5):e86. doi: 10.2196/resprot.7432.
Screening for colorectal cancer (CRC) significantly reduces mortality associated with this disease. In Australia, the National Bowel Cancer Screening Program provides regular fecal occult blood tests (FOBT) for those aged 50 to 74 years, however, participation rates in the program have plateaued at 36%. Given low uptake in the National Bowel Cancer Screening Program, it is necessary to explore alternate methods to increase CRC screening rates. Primary care is a promising adjunct setting to test methods to increase CRC screening participation. Primary care guidelines support the recommendation and provision of CRC screening to primary care patients. Those in the National Bowel Cancer Screening Program target age range frequently present to their primary care provider.
This study tests the effect that a multicomponent primary care-based intervention has on CRC screening uptake when compared to usual care.
Primary care patients presenting for an appointment with their primary care provider complete a touchscreen survey to determine eligibility for the trial. Those aged 50 to 74 years, at average risk of CRC, with no history of CRC or inflammatory bowel disease, who have not had an FOBT in the past 2 years or a colonoscopy in the past 5 years are eligible to participate in the trial. Trial participants are randomized to the intervention or usual care group by day of attendance at the practice. The intervention consists of provision of an FOBT, printed information sheet, and primary care provider endorsement to complete the FOBT. The usual care group receives no additional care.
The primary outcome is completion of CRC screening 6 weeks after recruitment. The proportion of patients completing CRC screening will be compared between trial groups using a logistic regression model.
CRC screening rates in Australia are suboptimal and interventions to increase screening participation are urgently required. This protocol describes the process of implementing a multicomponent intervention designed to increase CRC screening uptake in a primary care setting.
Australian New Zealand Clinical Trials Registry ACTRN12616001299493; https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371136&isReview=true (Archived by WebCite at http://www.webcitation.org/6pL0VYIj6). Universal Trial Number U1111-1185-6120.
结直肠癌(CRC)筛查能显著降低该疾病相关的死亡率。在澳大利亚,国家肠癌筛查项目为50至74岁的人群定期提供粪便潜血试验(FOBT),然而,该项目的参与率已稳定在36%。鉴于国家肠癌筛查项目的参与率较低,有必要探索其他方法来提高CRC筛查率。初级保健是测试提高CRC筛查参与率方法的一个有前景的辅助环境。初级保健指南支持向初级保健患者推荐并提供CRC筛查。国家肠癌筛查项目目标年龄范围内的人群经常前往他们的初级保健提供者处就诊。
本研究旨在测试与常规护理相比,基于初级保健的多组分干预对CRC筛查接受率的影响。
前来与初级保健提供者预约就诊的初级保健患者完成一项触摸屏调查,以确定是否符合试验条件。年龄在50至74岁、患CRC平均风险、无CRC或炎症性肠病病史、过去2年内未进行过FOBT或过去5年内未进行过结肠镜检查的患者有资格参与试验。试验参与者根据在诊所就诊的日期随机分为干预组或常规护理组。干预措施包括提供一次FOBT、打印的信息表以及初级保健提供者对完成FOBT的认可。常规护理组不接受额外护理。
主要结局是招募后6周内完成CRC筛查。将使用逻辑回归模型比较试验组之间完成CRC筛查的患者比例。
澳大利亚的CRC筛查率不理想,迫切需要采取干预措施来提高筛查参与率。本方案描述了在初级保健环境中实施旨在提高CRC筛查接受率的多组分干预的过程。
澳大利亚新西兰临床试验注册中心ACTRN12616001299493;https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371136&isReview=true(由WebCite存档于http://www.webcitation.org/6pL0VYIj6)。通用试验编号U1111 - 1185 - 6120。